Virtual assistant designed to support hematologists, medical and radiation oncologists, internal medicine, primary care, hematopoietic transplantation teams, and onco-hematology nursing staff in the diagnosis, treatment, and follow-up of Hodgkin lymphoma, based on the most up-to-date scientific evidence (NCCN, ESMO/EHA, BSH) and current guidelines as of August 2025.
Content automatically generated by an artificial intelligence system.It may contain inaccuracies.